At week 52 in a randomized, controlled trial, results suggest that tocilizumab is more effective than methotrexate in ...
MedPage Today on MSN
JAK Inhibitor Stays Effective Beyond 1 Year for Giant Cell Arteritis
Results from the trial's first year were reported at the 2024 ACR meeting, and they persuaded the FDA to approve the drug for ...
Disease-associated vision changes are common in GCA, with no significant difference in visual improvement observed with IV glucocorticoids vs oral therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback